News & Updates
Filter by Specialty:
Men with untreated hypogonadism at risk of long-term morbidity, death
Untreated hypogonadism in men appears to elevate the risk of morbidity in the long term and early mortality based on time-related measures of risk only, according to a study.
Men with untreated hypogonadism at risk of long-term morbidity, death
31 Jul 2022
Which drugs raise risk of urinary tract infections?
Some medications may directly cause the occurrence of urinary tract infections (UTIs), and a recent study presented at the 37th Annual European Association of Urology Congress (EAU 2022) has identified six drugs that appear to contribute to “significant reporting levels” for infections.
Which drugs raise risk of urinary tract infections?
29 Jul 2022
SOUNDS: Real-world use affirms efficacy, safety of sacral neuromodulator device for OAB
Delivering electric stimulation to the sacral nerves using an implantable device appears to be safe and effective in the treatment of overactive bladder (OAB) in a real-world setting, according to the France-based SOUNDS study presented at the 37th Annual European Association of Urology Congress (EAU 2022).
SOUNDS: Real-world use affirms efficacy, safety of sacral neuromodulator device for OAB
28 Jul 2022
Intravesical onabotA instillation safe, but with no clear benefit in urinary incontinence
The intravesical instillation of onabotulinumtoxinA (onabotA) for refractory overactive bladder in urinary incontinence is generally safe and well-tolerated, but demonstrates no significant efficacy advantage over placebo, according to a recent study.
Intravesical onabotA instillation safe, but with no clear benefit in urinary incontinence
28 Jul 2022
Short-course quinolones, pivmecillinam on par with standard regimens in uncomplicated cystitis
For women with acute uncomplicated cystitis, treatment regimens that include third- and fourth-generation quinolones and pivmecillinam can be administered in shorter courses, which perform similarly to the currently recommended regimens in terms of achieving symptomatic cure, according to the results of a meta-analysis presented at the 37th Annual European Association of Urology (EAU) Congress.
Short-course quinolones, pivmecillinam on par with standard regimens in uncomplicated cystitis
27 Jul 2022
Gut microbiota altered in prostate cancer
Men with prostate cancer have altered gut microbiota composition, according to a study presented at the recent Annual Congress of the European Association of Urology (EAU 2022). This association may partly explain the documented links between lifestyle or geographic location and prostate cancer.
